Late stage trial of Moderna’s COVID-flu vaccine shows robust immunity in elderly population

In a late-stage clinical trial, Moderna found that its combination flu and COVID vaccine elicited a robust immune response in older adults. The immune response levels were similar to those observed when the flu and COVID vaccines were administered separately.…